Absorption |
Blood-Brain Barrier | BBB+ | 0.9866 |
Human Intestinal Absorption | HIA+ | 0.9894 |
Caco-2 Permeability | Caco2+ | 0.7670 |
P-glycoprotein Substrate | Substrate | 0.7040 |
P-glycoprotein Inhibitor | Inhibitor | 0.6980 |
Inhibitor | 0.6302 |
Renal Organic Cation Transporter | Non-inhibitor | 0.5960 |
Distribution |
Subcellular localization | Mitochondria | 0.5070 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7990 |
CYP450 2D6 Substrate | Substrate | 0.6679 |
CYP450 3A4 Substrate | Non-substrate | 0.5000 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8586 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Inhibitor | 0.9102 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7651 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6685 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9849 |
Inhibitor | 0.8210 |
AMES Toxicity | Non AMES toxic | 0.7543 |
Carcinogens | Non-carcinogens | 0.8762 |
Fish Toxicity | High FHMT | 0.8242 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7604 |
Honey Bee Toxicity | Low HBT | 0.6588 |
Biodegradation | Not ready biodegradable | 0.9951 |
Acute Oral Toxicity | II | 0.6901 |
Carcinogenicity (Three-class) | Non-required | 0.6279 |